Management of chronic infectious diseases in schoolchildren /

Effective January 1, 1990, Public Act 86-890 (105 ILCS 5/10-21.11) required school boards "To develop policies and adopt rules relating to the appropriate manner of managing children with chronic infectious diseases, not inconsistent with guidelines published by the State Board of Education and the Illinois Department of Public Health." This is the document referenced in that law. During 2000, another task force was convened to update the document with the most current information concerning how to maintain school programs that will meet the health and educational needs of students who have chronic infectious diseases and to prevent the spread of diseases in the school setting ... It is hoped that this revision will assist local school district personnel in their efforts to maintain procedures and policies that will not compromise the safety of a classroom or a student's right to an education.

Potentially infectious medical waste.

Caption title.

Potentially infectious medical waste.

Caption title.

Potentially infectious medical waste.

Caption title.

Potentially infectious medical waste : a summary of regulatory requirements : livestock producer requirements.

"July 2003"

Potentially infectious medical waste : a summary of regulatory requirements : landfills special requirements.

"July 2003."

Potentially infectious medical waste : a summary of regulatory requirements : general requirements.

Caption title.

Equine infectious anemia : 2001 update /

Shipping list no.: 2004-0264-P.

Investigation of diseases of swine, and infectious and contagious diseases incident to other classes of domesticated animals.

Microfilmed for preservation

Microbes militant, a challenge to man; the story of modern preventive medicine and control of infectious diseases

Mode of access: Internet.

The registrar general's weekly return of births and deaths registered in county boroughs and other great towns and of cases of certain specified infectious diseases ... in England and Wales ...

Vols. for 1855-1912 include the publication: Annual summary of births, deaths and causes of death in London and other large towns; these precede the Weekly returns in the volumes.

Mortality and perinatal infectious complications following home birth in Washington State: 2003-2013

Thesis (Master's)--University of Washington, 2016-06

Co-existing conditions for deaths from infectious and parasitic diseases in Australia

Objective: To examine the frequency distribution of co-existing conditions for deaths where the underlying cause was infectious and parasitic diseases. Materials and methods: Besides the underlying cause of death, the distributions of co-existing conditions for deaths from infectious and parasitic diseases were examined in total and by various age and sex groups, at individual and chapter levels, using 1998 Australian mortality data. Results: In addition to the underlying cause of death, the average number of reported co-existing conditions for a single infectious and parasitic death was 1.62. The most common co-existing conditions were respiratory failure, acute renal failure non-specific causes, ischaemic heart disease, pneumonia and diabetes. When studying the distribution of co-existing conditions at the ICD-9 chapter level, it was found that the circulatory system diseases were the most important. There was an increasing trend in the number of reported co-existing conditions from 60 years of age upwards. Gender differences existed in the frequency of some reported co-existing conditions. The most common organism types of co-existing conditions were other bacterial infection and other viruses. Conclusions: The study indicated that the quality of death certificates is less than satisfactory for the 1998 Australian mortality data. The findings may be helpful in clarifying the ICD coding rules and the development of disease prevention strategies. (C) 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

A randomised trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases

Objective. Despite widespread adoption of home care services, few randomised trials have compared health outcomes in the hospital and at home. We report a prospective, randomised trial of home versus hospital therapy in adults receiving intravenous (IV) antibiotics. Our objective was to show that home care is a feasible alternative to hospitalisation over a broad range of infections, without compromise to quality of life (QOL) or clinical outcomes. Methods. Consenting adults requiring IV antibiotics were randomised to complete therapy at home or in hospital. Short Form 36 and Perceived Health Competence Scale (PHCS) were used for assessment of QOL. Statistical analysis used unpaired t-tests, Mann-Whitney tests and ANOVA. Results. One hundred and twenty-nine admissions were referred. Recruitment was hampered by patient preference for one therapy over another. 82 (62%) were included and randomised: 44 to home, 38 to hospital; the two groups had comparable characteristics. There were no differences in improvements in QOL and PHCS scores between the two groups after treatment. Treatment duration was median 11.5 days (range 3 - 57) and 11 days (range 4 - 126) for home and hospital groups, respectively. Home therapy costs, approximately, half that of hospital therapy. Time to readmission was longer after hospital therapy. Conclusion. Out study showed that home IV therapy is welt tolerated, is less costly, is not associated with any major disadvantage to QOL or clinical outcomes compared to hospital therapy, and is an appropriate treatment option for selected patients. (C) 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.